INCATE moderates webinar on "Project Management in Antimicrobial drug R&D"
| by Helena Costa Pereira
Webinar on "Project Management in Antimicrobial drug R&D"
Sina Gerbach,Program Manager at INCATE, has moderated the webinar on Project Management in Antimicrobial drug R&D. In this edition Kristina Orrling from Lygature and Global Antibiotic Research & Development Partnership (GARDP)'s R&D Portfolio and Planning Leader Julie Miralves have shared their expertise and insights on effective project management strategies in combating antibiotic resistance.
If you didn't have the chance to attend, you can now watch the whole webinar here.
About INCATE
INCATE is a not-for-profit partnership which brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe and beyond. The German Center for Infection Research (DZIF), the research association InfectControl in Germany, the Swiss National Centre of Competence in Research AntiResist, the University of Basel and the Leibniz-HKI are the academic founding members of INCATE with the University of Basel as virtual host. Together with the four industry partners Boehringer Ingelheim, Roche, Shionogi and MSD as well as other organizations, funders and investors, INCATE want to ensure that the pipeline of new antibiotics and diagnostics is filled and strengthened.
About REVIVE
The Global Antibiotic Research & Development Partnership (GARDP) launched REVIVE in January 2018 to ensure knowledge is retained, and the antimicrobial R&D community is supported to connect, share, and acquire information. With a network of world-class experts, REVIVE is an outreach activity to ensure knowledge is disseminated between clinical, industry and academic researchers at all stages of their careers. Through this, REVIVE helps to improve, accelerate, and streamline antimicrobial research and development.
About GARDP
The Global Antibiotic Research & Development Partnership (GARDP) accelerates the development and access of treatments for drug-resistant infections. Together with private, public and non-profit partners, GARDP works to preserve the power of antibiotics for generations to come.
